Nobiletin ameliorates cardiac impairment and alleviates cardiac remodeling after acute myocardial infarction in rats via JNK regulation

Nobiletin was found to protect against acute myocardial infarction (AMI)‐induced cardiac function decline and myocardial remodeling, although the dose–effect relationship and underlying pathways remained unclear. In the current research, different doses of Nobiletin (7.5, 15 and 30 mg/kg/day) were a...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zumei, Gao, Zhimin, Zeng, Lihuan, Liang, Zhenye, Zheng, Dechong, Wu, Xiaoqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931132/
https://www.ncbi.nlm.nih.gov/pubmed/33660406
http://dx.doi.org/10.1002/prp2.728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931132/
https://www.ncbi.nlm.nih.gov/pubmed/33660406
http://dx.doi.org/10.1002/prp2.728

Ejemplares similares